This Month in Psychopharmacology

FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease

The FDA has approved the first blood-based test to help diagnose Al...

Read More

Magnetic Stimulation to the Precuneus Shows Benefit in Alzheimer’s Patients

A recent study offers compelling clinical insights into the potenti...

Read More

Rheumatoid Arthritis Linked to Faster Cognitive Decline in Dementia Patient

Rheumatoid arthritis (RA) has been linked to an increased risk of d...

Read More

Alzheimer's Disease Awareness

During National Alzheimer’s Disease Awareness Month we’d like to hi...

Read More

Adult ADHD and Dementia

Every year NEI Fall Congress kicks off with multiple pre-conference...

Read More

Brief, Culturally Sensitive Screener Helps Primary Care Providers Diagnose Dementia

A brief and culturally fair cognitive assessment tool, paired with ...

Read More

FDA Approves New Alzheimer's Treatment

The U.S. Food and Drug Administration has approved a new treatment ...

Read More

Highlights from 2024 NEI Synapse: Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease

In her 2024 NEI Synapse presentation, Dr. Dani Cabral enlightened t...

Read More

Erectile Dysfunction Drugs May Protect Against Alzheimer’s

With Alzheimer’s disease (AD) cases projected to reach 157 million ...

Read More

Blood Test Predicts Who Might Benefit Most From Anti-Amyloid Drugs

The widely accepted Amyloid Cascade Hypothesis indicates that the m...

Read More

Gut Microbiome Composition May be an Indicator of Preclinical Alzheimer’s Disease

With Alzheimer’s disease (AD) becoming a global crisis, as lifespan...

Read More

Sleep-Disordered Breathing Tied to Brain Volumes in Amyloid-Positive Older Adults

Sleep-disordered breathing (SDB) has been associated with increased...

Read More